114 related articles for article (PubMed ID: 2261761)
1. Absorption kinetics of regular, isophane, and protamine zinc insulin in normal cats.
Wallace MS; Peterson ME; Nichols CE
Domest Anim Endocrinol; 1990 Oct; 7(4):509-15. PubMed ID: 2261761
[TBL] [Abstract][Full Text] [Related]
2. Absorption kinetics of regular and isophane (NPH) insulin in the normal dog.
Goeders LA; Esposito LA; Peterson ME
Domest Anim Endocrinol; 1987 Jan; 4(1):43-50. PubMed ID: 3333933
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.
Lepore M; Pampanelli S; Fanelli C; Porcellati F; Bartocci L; Di Vincenzo A; Cordoni C; Costa E; Brunetti P; Bolli GB
Diabetes; 2000 Dec; 49(12):2142-8. PubMed ID: 11118018
[TBL] [Abstract][Full Text] [Related]
4. Glargine and protamine zinc insulin have a longer duration of action and result in lower mean daily glucose concentrations than lente insulin in healthy cats.
Marshall RD; Rand JS; Morton JM
J Vet Pharmacol Ther; 2008 Jun; 31(3):205-12. PubMed ID: 18471141
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two ultralente insulin preparations with protamine zinc insulin in clinically normal cats.
Broussard JD; Peterson ME
Am J Vet Res; 1994 Jan; 55(1):127-31. PubMed ID: 8141485
[TBL] [Abstract][Full Text] [Related]
6. Dose-dependent subcutaneous absorption of porcine, bovine and human NPH insulins.
Hildebrandt P; Birch K; Sestoft L; Vølund A
Acta Med Scand; 1984; 215(1):69-73. PubMed ID: 6364700
[TBL] [Abstract][Full Text] [Related]
7. Absorption kinetics of short- and intermediate-acting insulins after jet injection with Medi-Jector II.
Houtzagers CM; Berntzen PA; van der Stap H; Heine RJ; van der Veen EA
Diabetes Care; 1988 Oct; 11(9):739-42. PubMed ID: 3066607
[No Abstract] [Full Text] [Related]
8. Factors influencing the absorption, serum insulin concentration, and blood glucose responses after injections of regular insulin and various insulin mixtures.
Galloway JA; Spradlin CT; Nelson RL; Wentworth SM; Davidson JA; Swarner JL
Diabetes Care; 1981; 4(3):366-76. PubMed ID: 7047113
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites.
Owens DR; Coates PA; Luzio SD; Tinbergen JP; Kurzhals R
Diabetes Care; 2000 Jun; 23(6):813-9. PubMed ID: 10841002
[TBL] [Abstract][Full Text] [Related]
10. Absorption of NPH (isophane) insulin in resting diabetic patients: evidence for subcutaneous injection in the thigh as the preferred site.
Henriksen JE; Vaag A; Hansen IR; Lauritzen M; Djurhuus MS; Beck-Nielsen H
Diabet Med; 1991 Jun; 8(5):453-7. PubMed ID: 1830531
[TBL] [Abstract][Full Text] [Related]
11. Five fold increase of insulin concentration delays the absorption of subcutaneously injected human insulin suspensions in pigs.
Jørgensen KH; Hansen AK; Buschard K
Diabetes Res Clin Pract; 2000 Dec; 50(3):161-7. PubMed ID: 11106830
[TBL] [Abstract][Full Text] [Related]
12. Miscibility of human semisynthetic regular and lente insulin and human biosynthetic regular and NPH insulin.
Olsson PO; Hans A; Henning VS
Diabetes Care; 1987; 10(4):473-7. PubMed ID: 3304898
[TBL] [Abstract][Full Text] [Related]
13. Comparison of one daily injection of NPH and crystalline PZI insulins on urinary glucose in diabetic children.
Mimouni M; Koivukangas T; Karp M; Laron Z
Acta Diabetol Lat; 1979; 16(1):63-6. PubMed ID: 377878
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the pharmacodynamics of protamine zinc insulin and insulin degludec and validation of the continuous glucose monitoring system iPro2 in healthy cats.
Salesov E; Zini E; Riederer A; Lutz TA; Reusch CE
Res Vet Sci; 2018 Jun; 118():79-85. PubMed ID: 29421488
[TBL] [Abstract][Full Text] [Related]
15. Study of porcine and human isophane (NPH) insulins in normal subjects.
Owens DR; Jones IR; Birtwell AJ; Burge CT; Luzio S; Davies CJ; Heyburn P; Heding LG
Diabetologia; 1984 Apr; 26(4):261-5. PubMed ID: 6376233
[TBL] [Abstract][Full Text] [Related]
16. Treatment of newly diagnosed diabetic cats with glargine insulin improves glycaemic control and results in higher probability of remission than protamine zinc and lente insulins.
Marshall RD; Rand JS; Morton JM
J Feline Med Surg; 2009 Aug; 11(8):683-91. PubMed ID: 19539509
[TBL] [Abstract][Full Text] [Related]
17. Exercise augments the absorption of isophane (NPH) insulin.
Thow JC; Johnson AB; Antsiferov M; Home PD
Diabet Med; 1989; 6(4):342-5. PubMed ID: 2524341
[TBL] [Abstract][Full Text] [Related]
18. Different absorption of isophane (NPH) insulin from subcutaneous and intramuscular sites suggests a need to reassess recommended insulin injection technique.
Thow JC; Johnson AB; Fulcher G; Home PD
Diabet Med; 1990 Aug; 7(7):600-2. PubMed ID: 2146067
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability and variability of biphasic insulin mixtures.
Søeborg T; Rasmussen CH; Mosekilde E; Colding-Jørgensen M
Eur J Pharm Sci; 2012 Jul; 46(4):198-208. PubMed ID: 21703346
[TBL] [Abstract][Full Text] [Related]
20. The contribution of intermediate-acting insulin preparations to daytime insulin treatment.
Robert JJ; Chevenne D; Debray M
Diabet Med; 1989 Aug; 6(6):531-6. PubMed ID: 2527136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
